2020 Bulkers Ltd. (OSL:2020)
Norway · Delayed Price · Currency is NOK 126.10
-1.90 (-1.48%)
Aug 1, 2025, 4:25 PM CET
Marinus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
Cash & Equivalents | 16.8 | 16.1 | 30.7 | 15.5 | 24 | 19.9 | Upgrade |
Trading Asset Securities | - | - | 4 | 5.8 | 0.4 | 0.2 | Upgrade |
Cash & Short-Term Investments | 16.8 | 16.1 | 34.7 | 21.3 | 24.4 | 20.1 | Upgrade |
Cash Growth | -69.73% | -53.60% | 62.91% | -12.71% | 21.39% | - | Upgrade |
Accounts Receivable | 0.8 | 1.1 | 1.1 | 2.4 | 0.9 | 0.7 | Upgrade |
Receivables | 0.8 | 1.1 | 1.1 | 2.4 | 0.9 | 0.7 | Upgrade |
Restricted Cash | 0.3 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | Upgrade |
Other Current Assets | 3.7 | 1.9 | 2.8 | 3.5 | 2.8 | 2.3 | Upgrade |
Total Current Assets | 21.6 | 19.2 | 38.7 | 27.4 | 28.2 | 23.2 | Upgrade |
Property, Plant & Equipment | 247.6 | 247.4 | 337.4 | 349 | 360.6 | 372.3 | Upgrade |
Long-Term Investments | - | - | - | 3.4 | 1.1 | - | Upgrade |
Other Long-Term Assets | - | - | - | - | 0.7 | 0.2 | Upgrade |
Total Assets | 269.2 | 266.6 | 376.1 | 379.8 | 390.6 | 395.7 | Upgrade |
Accounts Payable | 1.4 | 0.5 | 0.6 | 1 | 0.7 | 0.6 | Upgrade |
Accrued Expenses | 4.2 | 3.1 | 3.5 | 2.9 | 3.2 | 3 | Upgrade |
Current Portion of Long-Term Debt | - | - | 14.8 | 14.8 | 15 | 15.1 | Upgrade |
Current Unearned Revenue | 2.7 | 0.7 | 2.3 | 1 | - | - | Upgrade |
Other Current Liabilities | 0.5 | 0.3 | 4.8 | 0.9 | 2.4 | 2.3 | Upgrade |
Total Current Liabilities | 8.8 | 4.6 | 26 | 20.6 | 21.3 | 21 | Upgrade |
Long-Term Debt | 110.3 | 110.1 | 125.1 | 134.4 | 143.9 | 154 | Upgrade |
Long-Term Leases | - | - | 64 | 68.8 | 73.6 | 78.4 | Upgrade |
Other Long-Term Liabilities | - | - | - | 0.1 | 0.1 | 0.2 | Upgrade |
Total Liabilities | 119.1 | 114.7 | 215.1 | 223.9 | 238.9 | 253.6 | Upgrade |
Common Stock | 22.9 | 22.9 | 22.9 | 22.2 | 22.2 | 22.2 | Upgrade |
Additional Paid-In Capital | 11.8 | 13.1 | 12.7 | 28.7 | 64.7 | 116.9 | Upgrade |
Retained Earnings | 115.3 | 115.8 | 121.4 | 95.8 | 63.9 | 4.4 | Upgrade |
Comprehensive Income & Other | - | - | 4 | 9.2 | 0.9 | -1.4 | Upgrade |
Total Common Equity | 150 | 151.8 | 161 | 155.9 | 151.7 | 142.1 | Upgrade |
Minority Interest | 0.1 | 0.1 | - | - | - | - | Upgrade |
Shareholders' Equity | 150.1 | 151.9 | 161 | 155.9 | 151.7 | 142.1 | Upgrade |
Total Liabilities & Equity | 269.2 | 266.6 | 376.1 | 379.8 | 390.6 | 395.7 | Upgrade |
Total Debt | 110.3 | 110.1 | 203.9 | 218 | 232.5 | 247.5 | Upgrade |
Net Cash (Debt) | -93.5 | -94 | -169.2 | -196.7 | -208.1 | -227.4 | Upgrade |
Net Cash Per Share | -4.09 | -4.11 | -7.50 | -8.73 | -9.23 | -10.26 | Upgrade |
Filing Date Shares Outstanding | 22.87 | 22.87 | 22.87 | 22.22 | 22.22 | 22.17 | Upgrade |
Total Common Shares Outstanding | 22.87 | 22.87 | 22.87 | 22.22 | 22.22 | 22.17 | Upgrade |
Working Capital | 12.8 | 14.6 | 12.7 | 6.8 | 6.9 | 2.2 | Upgrade |
Book Value Per Share | 6.56 | 6.64 | 7.04 | 7.02 | 6.83 | 6.41 | Upgrade |
Tangible Book Value | 150 | 151.8 | 161 | 155.9 | 151.7 | 142.1 | Upgrade |
Tangible Book Value Per Share | 6.56 | 6.64 | 7.04 | 7.02 | 6.83 | 6.41 | Upgrade |
Machinery | 287.9 | 290.5 | 383.4 | 383.4 | 383.4 | 383.4 | Upgrade |
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.